Population
Human subjects
Design
Other
Authors
Loading...
May inform weight-based heparin dosing and assay selection now; leaves open optimal monitoring strategies pending modern outcome trials.
The half-life of intravenous heparin is approximately 1.5 hours, with the whole-blood activated partial thromboplastin time identified as the most precise and economical assay for monitoring its effect.
J. Worth Estes (1970) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: